FNY Investment Advisers’s Audentes Therapeutics, Inc BOLD Stock Holding History

FNY Investment Advisers’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-278,861	Closed	-$16.7M	–	997
2019 Q4	$16.7M	Buy	+278,861	New	+$10.5M	5.17%	2
2019 Q3	–	Sell	-405	Closed	-$15K	–	1301
2019 Q2	$15K	Buy	+405	New	+$15.6K	﹤0.01%	539

FNY Investment Advisers's BOLD Position: Q1 2020 in Review

FNY Investment Advisers sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 278,861 shares — an estimated $16.7M sold.

FNY Investment Advisers first reported a position in BOLD in Q2 2019 and held it in 2 quarters. The position peaked at $16.7M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

FNY Investment Advisers reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
FNY Investment Advisers sold 278,861 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $16.7M.
FNY Investment Advisers first reported a position in Audentes Therapeutics, Inc in Q2 2019 and held it in 2 quarters.
FNY Investment Advisers's Audentes Therapeutics, Inc position peaked at $16.7M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on FNY Investment Advisers's 13F filing for Q1 2020, filed 9 Apr 2020.